TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers

Conditions:   Solid Tumor;   Lymphoma
Interventions:   Drug: TTX-030;   Drug: Pembrolizumab;   Drug: Docetaxol;   Drug: Gemcitabine;   Drug: nab paclitaxel
Sponsor:   Tizona Therapeutics, Inc
Recruiting
ClinicalTrials.gov: Pancreatic | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days